CVR Medical Corp. (CRRVF) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
CVR Medical Corp. (CRRVF) trades at $0.00001 with AI Score 45/100 (Grade C). CVR Medical Corp. is a North Vancouver-based healthcare company specializing in advanced acoustic wave analysis technology for medical diagnostics. Sector: Healthcare.
Price as of Aug 21, 2026 · Last analyzed: Jun 15, 2026Analyst Coverage for CRRVF: CRRVF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates CRRVF against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
CRRVF: 1/3 scored disciplines lean bearish. Dominant signal: Izzy Englander bullish.
How is this calculated? →Why this analysis is different
- A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
- An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
- Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.
CVR Medical Corp. (CRRVF) Healthcare & Pipeline Overview
CVR Medical Corp. leverages innovative acoustic wave analysis technology to enhance diagnostic accuracy in cardiovascular health, addressing a critical need in the healthcare sector for early detection and intervention.
What Is the Investment Thesis for CRRVF?
CVR Medical Corp. presents a unique investment thesis driven by its proprietary carotid stenotic scan device, which addresses a critical market need for early detection of cardiovascular diseases. The global market for cardiovascular diagnostics is projected to grow significantly, with estimates suggesting a CAGR of over 7% through 2030. The company’s focus on advanced acoustic wave analysis technology provides a competitive edge, particularly in non-invasive diagnostics. However, investors should remain aware of the risks associated with regulatory approvals and the challenges of operating as an OTC Other listed company, which may affect liquidity and information availability. Monitoring clinical trial outcomes and market acceptance will be crucial for assessing the company’s growth trajectory.
Based on FMP financials and quantitative analysis
CRRVF Key Highlights
Market Cap: $0.00B, indicating a current lack of market valuation.
- Beta: 1.91, suggesting higher volatility compared to the market.
- Dividend Yield: None, as the company does not currently pay dividends.
- Focus on non-invasive diagnostics, a growing segment in the healthcare industry.
- Established in 1980, indicating over 40 years of experience in the medical technology sector.
Who Are CRRVF's Competitors?
CRRVF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| MDT Medtronic plc | $92.88 | -1.33% | $119B | 77 |
| SYK Stryker Corporation | $340.11 | +0.04% | $131B | 79 |
| ABT Abbott Laboratories | $114.26 | -0.15% | $198B | 70 |
| CNVIF Conavi Medical Corp. | $0.13 | -1.19% | $11.4M | 66 |
| VPTDF VentriPoint Diagnostics Ltd. | $0.07 | -4.02% | $13.8M | 62 |
| LHDX Lucira Health, Inc. | $0.45 | +0.00% | $18.4M | 64 |
| PLSM PLSM | $3.01 | +4.88% | $19.6M | 60 |
| PYNKF Perimeter Medical Imaging AI, Inc. | $0.27 | -1.08% | $24.6M | 73 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are CRRVF's Key Strengths?
Innovative technology focused on non-invasive diagnostics.
- Strong emphasis on research and development capabilities.
- Established presence in the healthcare industry since 1980.
What Are CRRVF's Weaknesses?
Limited financial resources as indicated by a market cap of $0.00B.
- Higher risks associated with being an OTC Other listed company.
- Potential challenges in scaling operations and production.
What Could Drive CRRVF Stock Higher?
Regulatory approvals for the carotid stenotic scan device, which could significantly enhance market entry.
- Development of strategic partnerships with healthcare providers to facilitate adoption of the diagnostic technology.
- Potential announcements regarding clinical trial results that may validate the effectiveness of the carotid stenotic scan device.
What Are the Key Risks for CRRVF?
Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
- Regulatory hurdles that could delay product launches.
- Market competition from established medical device companies.
- Risks associated with being an OTC Other listed company, including liquidity issues.
What Are the Growth Opportunities for CRRVF?
- Growth opportunity 1: The global market for cardiovascular diagnostics is projected to reach over $20 billion by 2030, growing at a CAGR of 7%. CVR Medical Corp.'s carotid stenotic scan device is well-positioned to capture market share as healthcare providers increasingly adopt non-invasive diagnostic technologies. The device's ability to provide accurate assessments of carotid artery health can lead to earlier interventions, appealing to a broad range of healthcare stakeholders.
- Growth opportunity 2: Increasing awareness of cardiovascular health and preventive care is driving demand for innovative diagnostic solutions. As public health initiatives promote early detection of cardiovascular diseases, CVR Medical's technology aligns perfectly with these trends. The company can leverage partnerships with healthcare organizations and educational campaigns to enhance visibility and adoption of its carotid stenotic scan device.
- Growth opportunity 3: Advances in telemedicine and remote patient monitoring are creating new avenues for CVR Medical to expand its market reach. By integrating its diagnostic devices with telehealth platforms, the company can offer healthcare providers the ability to conduct remote assessments, thereby enhancing patient access to care and improving overall health outcomes. This trend is expected to grow significantly in the coming years.
- Growth opportunity 4: Regulatory approvals for innovative medical devices can significantly enhance market entry and expansion. CVR Medical is actively pursuing necessary certifications and approvals for its carotid stenotic scan device, which could open new markets and increase its credibility among healthcare professionals. Successful navigation of the regulatory landscape will be critical for the company’s growth.
- Growth opportunity 5: Strategic partnerships with insurance providers can enhance the adoption of CVR Medical's diagnostic tools. By demonstrating the cost-effectiveness and clinical benefits of early detection through its technology, the company can negotiate favorable reimbursement policies, incentivizing healthcare providers to integrate its device into standard practice.
What Are CRRVF's Competitive Advantages?
- Proprietary technology in acoustic wave analysis for medical diagnostics.
- Focus on non-invasive procedures, enhancing patient comfort and compliance.
- Established brand presence with over 40 years in the healthcare sector.
What Does CRRVF Do?
Established in 1980 and headquartered in North Vancouver, Canada, CVR Medical Corp. has carved a niche in the healthcare sector by focusing on the research and development of advanced acoustic wave analysis technologies. The company's flagship product, the carotid stenotic scan device, is engineered to accurately identify and quantify narrowing within the carotid arteries, which is crucial for assessing the risk of stroke and other cardiovascular diseases. This innovative technology not only aids patients but also serves insurance providers and medical professionals by facilitating timely diagnoses and treatment plans. Over the years, CVR Medical has evolved from a research-focused entity to a more product-oriented company, emphasizing the commercialization of its proprietary technologies. The carotid stenotic scan device represents a significant advancement in non-invasive diagnostic tools, positioning CVR Medical as a key player in the medical device industry. With a growing emphasis on preventative healthcare and early disease detection, CVR Medical is well-positioned to meet the increasing demand for innovative diagnostic solutions in cardiovascular health.
What Products and Services Does CRRVF Offer?
- Develop advanced acoustic wave analysis technology for medical applications.
- Create diagnostic instruments for identifying cardiovascular diseases.
- Focus on non-invasive techniques to improve patient comfort and outcomes.
- Target healthcare providers, insurance companies, and patients with innovative solutions.
- Conduct research and development to enhance existing medical technologies.
- Aim to improve early detection and treatment of carotid artery diseases.
How Does CRRVF Make Money?
- Generate revenue through the sale of diagnostic devices and technologies.
- Partner with healthcare providers for product integration and usage.
- Explore licensing agreements for proprietary technology.
- Focus on research grants and funding for ongoing development projects.
What Industry Does CRRVF Operate In?
The medical devices industry is experiencing robust growth, driven by increasing healthcare expenditures and a rising focus on preventative care. The global cardiovascular diagnostics market is expanding, with a projected size of over $20 billion by 2030, reflecting a growing demand for innovative diagnostic solutions. CVR Medical Corp. operates within this competitive landscape, where rapid technological advancements and regulatory changes are common. The company’s emphasis on non-invasive diagnostic tools positions it favorably against traditional methods, appealing to both healthcare providers and patients seeking safer and more efficient diagnostic options.
Who Are CRRVF's Key Customers?
- Healthcare providers looking for advanced diagnostic tools.
- Insurance companies interested in cost-effective healthcare solutions.
- Patients requiring non-invasive assessments of cardiovascular health.
How CVR Medical Corp. Is Valued
Relative to its peer group, CRRVF's quantitative score of 45/100 is below the peer average of 71/100.
Company Profile
CVR Medical Corp. operates in the Medical - Devices industry within the Healthcare sector. It is headquartered in North Vancouver, CA. The company is led by CEO Darren Day. CRRVF has traded publicly since 2016.
Key Financial Metrics
Return on equity for CVR Medical Corp. stands at 50.5%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.02 means current liabilities exceed short-term assets, a liquidity point worth watching.
Financial Health
CVR Medical Corp.'s Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
CRRVF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in CVR Medical's future prospects, indicating a belief in the company's potential growth.
- Community sentiment has shifted positively as new product developments gain attention, fostering a sense of optimism among investors.
- Analysts have noted increasing interest in the medical sector, particularly in innovative health technologies, which could benefit CVR Medical.
- The company has made strides in enhancing its technology, positioning itself favorably within the competitive landscape of medical devices.
Bear Case
- Concerns over regulatory hurdles persist, with some investors wary of the time it may take for new products to gain approval.
- Recent discussions in trading communities reveal skepticism about the company's ability to scale operations effectively amid market competition.
- There are lingering doubts regarding the sustainability of recent positive sentiment, as some investors remain cautious about long-term viability.
- Market perception has been tempered by broader economic uncertainties, leading to a more cautious outlook among potential investors.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
CRRVF Latest News
No recent news available for CRRVF.
CRRVF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CRRVF.
Price Targets
Wall Street price target analysis for CRRVF.
CRRVF MoonshotScore
What does this score mean?
The MoonshotScore rates CRRVF 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Darren Day
CEO
Darren Day has a diverse background in healthcare management and technology innovation. He has held various leadership roles in medical technology companies, focusing on product development and market strategy. With a strong educational foundation in biomedical engineering and business administration, Darren brings a wealth of knowledge to CVR Medical Corp.
Track Record: Under Darren's leadership, CVR Medical has made significant strides in developing its carotid stenotic scan device, positioning the company for potential growth in the cardiovascular diagnostics market. His strategic vision has been instrumental in navigating the challenges of the healthcare landscape.
CRRVF OTC Market Information
The OTC Other tier includes companies that do not meet the criteria for higher tiers like OTCQX or OTCQB, often resulting in less stringent reporting requirements. This may lead to lower liquidity and increased risks for investors due to limited information availability.
- OTC Tier: OTC Other
- Higher volatility and risk associated with OTC stocks.
- Limited financial disclosure may hinder informed investment decisions.
- Potential for lower investor interest and trading volume.
- Verify the company's financial health through available reports.
- Assess the regulatory status of the carotid stenotic scan device.
- Research the competitive landscape and market positioning.
- Evaluate the management team's track record and expertise.
- Monitor upcoming clinical trials and product approvals.
- Established company with over 40 years in the healthcare sector.
- Focus on innovative medical technology with potential market impact.
- Engagement in research and development to enhance product offerings.
What Investors Ask About CVR Medical Corp. (CRRVF) — Healthcare
What does the AI Score mean for CRRVF?
CRRVF holds an AI Score of 45/100 (Grade: C). This is an educational research signal, not a buy or sell recommendation. CVR Medical Corp. is a North Vancouver-based healthcare company specializing in advanced acoustic wave analysis technology for medical diagnostics. Its primary product, the carotid stenotic scan …
What does CVR Medical Corp. do?
CVR Medical Corp. specializes in developing advanced acoustic wave analysis technology for medical diagnostics, particularly focusing on its carotid stenotic scan device. This device is designed to accurately identify and quantify narrowing in the carotid arteries, which is crucial for assessing stroke risk and other cardiovascular conditions. The company's technology aims to improve early detection and treatment of cardiovascular diseases, benefiting healthcare providers and patients alike.
How does CVR Medical Corp. manage patent expiration risks?
CVR Medical Corp. actively manages patent expiration risks by investing in continuous research and development to innovate and enhance its product offerings. The company aims to extend the lifecycle of its technologies through improvements and new applications, thereby mitigating the impact of potential competition from generic alternatives. Additionally, CVR Medical may explore licensing agreements and partnerships to further protect its intellectual property and maintain a competitive edge.
What are the main risks for CRRVF?
CVR Medical Corp. faces several risks, including regulatory hurdles that could delay product approvals and market entry. As an OTC Other listed company, it also experiences higher volatility and liquidity risks, which may affect trading and investment decisions.
What are the key factors to evaluate for CRRVF?
CVR Medical Corp. (CRRVF) holds an AI score of 45/100 (low). presents a unique investment thesis driven by its proprietary carotid stenotic scan device, which addresses a critical market need for early detection of cardiovascular diseases. Not financial advice.
How frequently does CRRVF data refresh on this page?
CRRVF's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven CRRVF's recent stock price performance?
CVR Medical Corp. (CRRVF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Innovative technology focused on non-invasive diagnostics. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider CRRVF overvalued or undervalued right now?
CVR Medical Corp. (CRRVF) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research CRRVF before investing?
Before investing in CVR Medical Corp. (CRRVF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- The company's financial status is currently limited due to its OTC classification.